FIGURE 1.
Predicted and observed mean plasma concentration–time curves of apatinib following a single oral dose of apatinib mesylate tablet in healthy volunteers (A,B) and in cancer patients (C).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.